184 related articles for article (PubMed ID: 36789545)
1. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
3. Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
de Rooij JD; Masetti R; van den Heuvel-Eibrink MM; Cayuela JM; Trka J; Reinhardt D; Rasche M; Sonneveld E; Alonzo TA; Fornerod M; Zimmermann M; Pigazzi M; Pieters R; Meshinchi S; Zwaan CM; Locatelli F
Blood; 2016 Jun; 127(26):3424-30. PubMed ID: 27114462
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921
[TBL] [Abstract][Full Text] [Related]
5. Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene.
Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
[TBL] [Abstract][Full Text] [Related]
6. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
de Rooij JD; Hollink IH; Arentsen-Peters ST; van Galen JF; Berna Beverloo H; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Zimmermann M; Alonzo TA; Pieters R; Meshinchi S; van den Heuvel-Eibrink MM; Zwaan CM
Leukemia; 2013 Dec; 27(12):2280-8. PubMed ID: 23531517
[TBL] [Abstract][Full Text] [Related]
7. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
Chisholm KM; Heerema-McKenney AE; Choi JK; Smith J; Ries RE; Hirsch BA; Raimondi SC; Alonzo TA; Wang YC; Aplenc R; Sung L; Gamis AS; Meshinchi S; Kahwash SB
Blood Adv; 2020 Dec; 4(23):6000-6008. PubMed ID: 33284945
[TBL] [Abstract][Full Text] [Related]
8. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
[TBL] [Abstract][Full Text] [Related]
9. Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristics.
Panda D; Chatterjee G; Sardana R; Khanka T; Ghogale S; Deshpande N; Badrinath Y; Shetty D; Narula G; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
Cytometry B Clin Cytom; 2021 Mar; 100(2):206-217. PubMed ID: 32865882
[TBL] [Abstract][Full Text] [Related]
10. Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
de Rooij JD; Branstetter C; Ma J; Li Y; Walsh MP; Cheng J; Obulkasim A; Dang J; Easton J; Verboon LJ; Mulder HL; Zimmermann M; Koss C; Gupta P; Edmonson M; Rusch M; Lim JY; Reinhardt K; Pigazzi M; Song G; Yeoh AE; Shih LY; Liang DC; Halene S; Krause DS; Zhang J; Downing JR; Locatelli F; Reinhardt D; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M; Gruber TA
Nat Genet; 2017 Mar; 49(3):451-456. PubMed ID: 28112737
[TBL] [Abstract][Full Text] [Related]
11. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
Abla O; Ries RE; Triche T; Gerbing RB; Hirsch B; Raimondi S; Cooper T; Farrar JE; Buteyn N; Harmon LM; Wen H; Deshpande AJ; Kolb EA; Gamis AS; Aplenc R; Alonzo T; Meshinchi S
Blood Adv; 2024 Apr; 8(8):2005-2017. PubMed ID: 38306602
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of chimeric fusion gene analysis in pediatric acute megakaryoblastic leukemia].
Tamefusa K; Fukutake K; Ishida H; Tamura A; Endo M; Hamamoto K; Koga Y; Yamada M; Kanamitsu K; Fujiwara K; Washio K; Shimada A
Rinsho Ketsueki; 2019; 60(2):99-105. PubMed ID: 30842387
[TBL] [Abstract][Full Text] [Related]
13. Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.
Masetti R; Bertuccio SN; Astolfi A; Chiarini F; Lonetti A; Indio V; De Luca M; Bandini J; Serravalle S; Franzoni M; Pigazzi M; Martelli AM; Basso G; Locatelli F; Pession A
J Hematol Oncol; 2017 Jan; 10(1):26. PubMed ID: 28109323
[TBL] [Abstract][Full Text] [Related]
14. CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.
Masetti R; Bertuccio SN; Pession A; Locatelli F
Br J Haematol; 2019 Feb; 184(3):337-347. PubMed ID: 30592296
[TBL] [Abstract][Full Text] [Related]
15. Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report.
Gillam J; Catic A; Paulraj P; Dalton J; Lai G; Jackson-Cook C; Turner S; Ferreira-Gonzalez A; Barrie E
Genes Chromosomes Cancer; 2022 Aug; 61(8):491-496. PubMed ID: 35294081
[TBL] [Abstract][Full Text] [Related]
16. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA
Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Transcriptome Profiling of Cryptic
Smith JL; Ries RE; Hylkema T; Alonzo TA; Gerbing RB; Santaguida MT; Eidenschink Brodersen L; Pardo L; Cummings CL; Loeb KR; Le Q; Imren S; Leonti AR; Gamis AS; Aplenc R; Kolb EA; Farrar JE; Triche TJ; Nguyen C; Meerzaman D; Loken MR; Oehler VG; Bolouri H; Meshinchi S
Clin Cancer Res; 2020 Feb; 26(3):726-737. PubMed ID: 31719049
[TBL] [Abstract][Full Text] [Related]
18. The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.
Masetti R; Guidi V; Ronchini L; Bertuccio NS; Locatelli F; Pession A
Crit Rev Oncol Hematol; 2019 Jun; 138():132-138. PubMed ID: 31092368
[TBL] [Abstract][Full Text] [Related]
19. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric
Pollard JA; Guest E; Alonzo TA; Gerbing RB; Loken MR; Brodersen LE; Kolb EA; Aplenc R; Meshinchi S; Raimondi SC; Hirsch B; Gamis AS
J Clin Oncol; 2021 Oct; 39(28):3149-3160. PubMed ID: 34048275
[TBL] [Abstract][Full Text] [Related]
20. CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.
Gress V; Roussy M; Boulianne L; Bilodeau M; Cardin S; El-Hachem N; Lisi V; Khakipoor B; Rouette A; Farah A; Théret L; Aubert L; Fatima F; Audemard É; Thibault P; Bonneil É; Chagraoui J; Laramée L; Gendron P; Jouan L; Jammali S; Paré B; Simpson SM; Tran TH; Duval M; Teira P; Bittencourt H; Santiago R; Barabé F; Sauvageau G; Smith MA; Hébert J; Roux PP; Gruber TA; Lavallée VP; Wilhelm BT; Cellot S
Blood Adv; 2024 Jan; 8(1):112-129. PubMed ID: 37729615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
